No headlines found.
No press releases found.
No news found.
The Fund seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index (the "Index"). The Index is provided by S&P Dow Jones Indices (the "Index Provider") and includes domestic companies from the healthcare sector, which includes the following industries: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology. The Fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments, securities of the Index, and exchange-traded funds ("ETFs") that track the Index, that, in combination, provide 3X daily leveraged exposure to the Index, consistent with the Fund's investment objective. The financial instruments in which the Fund most commonly invests are swap agreements and futures agreements which are intended to produce economically leveraged investment results.
Direxion Daily Healthcare Bull 3X ETF trades on the ARCA stock market under the symbol CURE.
As of August 7, 2026, CURE stock price climbed to $125.18 with 72,582 million shares trading.
CURE has a beta of 0.56, meaning it tends to be less sensitive to market movements. CURE has a correlation of 0.02 to the broad based SPY ETF.
CURE has a market cap of $181.51 million. This is considered a Micro Cap stock.
In the last 3 years, CURE traded as high as $143.51 and as low as $66.00.
CURE has outperformed the market in the last year with a price return of +80.3% while the SPY ETF gained +23.4%. CURE has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +42.4% and +7.8%, respectively, while the SPY returned +5.6% and +4.7%, respectively.
CURE support price is $117.74 and resistance is $126.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CURE shares will trade within this expected range on the day.
